Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

VALEANT PHARMACEUTICALS INTL INC T.VRX

"Valeant Pharmaceuticals is a global specialty pharmaceutical firm with a focus on branded products for the dermatology, gastrointestinal, and ophthalmology markets. The firm also has a branded generics business that operates primarily in Latin America, Eastern Europe, and Asia."


TSX:VRX - Post by User

Post by kthanxon Oct 19, 2016 1:14pm
384 Views
Post# 25361550

Long on Valeant

Long on ValeantThis stock is sputtering from the recent rally due to a lack of news.

There are 3 key catalysts coming up and each of those news releases should push the stock forward aggressively,

Analyst ratings in the last 3 months for target price.

Duetche Bank - $29
RBC - $35
Morgan Stanley - $42
Mizuho - $25 (biggest bear)
Rodman and Renshaw - $90

Even if the stock goes to a modest $35 that is huge gains from current level.
<< Previous
Bullboard Posts
Next >>